
News|Articles|December 1, 2001
Bioterror response to alter pharmaceutical development and marketing
Uncle Sam is poised to authorize more than $1 billion to buy medicines and vaccines for the national pharmaceutical stockpile, and federal agencies are gearing up to spend millions more on research related to infectious disease. In response, the pharmaceutical industry is assessing how these developments may alter the way it does business.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Tackling Health Inequities Through Collaboration and Community-Based Care
2
Celiac Disease and Thyroid Disease in Adolescence Linked to the Development of Type 1 Diabetes in Adulthood
3
Optimal Physical Activity for Preventing Digestive System Cancers
4
Fulton County Leaders Discuss Closing Health Gaps and Strengthening Behavioral Health Systems
5
















































